NHS England Low Priority Treatment - Dronedarone

Below are the database queries which are used to create this measure. These are run against a copy of the BSA prescribing data which we store in Google BigQuery. We're working on making our BigQuery tables publicly available at which point it will be possible to run and modify these queries yourself. But even where code and database queries are not directly useable by others we believe it is always preferable to make them public.

Description	Cost of Dronedarone per 1000 patients
Why it matters	Dronedarone was originally approved to prevent recurrence of atrial fibrillation, or to lower the heart rate in adults who have had or have non-permanent atrial fibrillation. In September 2011 this indication was restricted to the maintenance of normal heart rhythm in ‘persistent’ or ‘paroxysmal’ atrial fibrillation after normal heart rhythm has been restored. NICE clinical guideline on Atrial Fibrillation puts greater emphasis on rate rather than rhythm control and has clarified the place of dronedarone in the treatment pathway.
Tags	Cost Saving, Cardiovascular system, NHS England Low Priority, Cardiovascular system, NICE, Safety
Implies cost savings	Yes
History	View change history on GitHub →

Numerator SQL

SELECT
     CAST(month AS DATE) AS month,
     practice AS practice_id,
     SUM(actual_cost) AS numerator
 FROM hscic.normalised_prescribing
 WHERE bnf_code IN ("0203020X0AAAAAA", "0203020X0BBAAAA")
 GROUP BY month, practice_id

Denominator SQL

SELECT
     CAST(month AS DATE) AS month,
     practice AS practice_id,
     SUM(total_list_size / 1000.0) AS denominator
 FROM hscic.practice_statistics
 GROUP BY month, practice_id